Pre-release benchmarks for Intel's Battlemage GPU architecture have leaked, placing the top-tier consumer Battlemage part — reportedly the Arc B770 — roughly between the RTX 4070 and RTX 4070 Ti in rasterisation workloads, depending on the title and API version used.
Why This Is More Significant Than the Numbers Suggest
The comparison is more favourable to Intel than it might appear from the numbers alone. The original Alchemist (Arc A770, A750) launch was seriously undermined by poor driver maturity at release and inconsistent performance in DX11 games. By the time drivers had improved to a competitive state, the product cycle was already winding down.
Battlemage benefits from a full generation of driver development. The leaked results reportedly show consistent performance across both DX12 and DX11 titles — the latter having been Alchemist's most notable weakness.
XeSS Improvements
Intel's XeSS upscaling technology has continued to develop since Alchemist. Version 2 and beyond show image quality competitive with FSR 3 in most tests, and some comparisons suggest it approaches DLSS quality on Intel hardware. Combined with better rasterisation baselines, the value proposition is more coherent than Alchemist could offer.
The Pricing Question
Pricing remains the open variable. If Intel positions Battlemage aggressively in the AUD $500–650 range, it creates meaningful three-way competition at a tier where the majority of gaming GPUs are purchased. If pricing matches NVIDIA equivalents, driver maturity concerns — even if reduced — will still cause hesitation among buyers with Alchemist memories.
The Broader Benefit
For the PC building community, Battlemage's success would be broadly positive regardless of brand preference. Three-way competition at the midrange is the most direct path to better value across all options.